Scope Forward

By Praveen Suthrum

No one in the medical field is free from the impact of COVID-19, including gastroenterologists. But the pandemic has only accelerated trends that started years ago. In this podcast, Praveen Suthrum in... more

5

44 ratings

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Scope Forward:

How many episodes does Scope Forward have?

The podcast currently has 77 episodes available.

Scope Forward episodes:

July 28, 2022 Dr. Haytham Gareer: RNA stool test with 95% accuracy to increase colonoscopies
In this episode of The Scope Forward Show, Praveen Suthrum interviews Dr. Haytham Gareer, Chief Medical Officer, Geneoscopy (RNA stool testing company).
In November 2021, a month after Dr. Haytham Gareer joined Geneoscopy as CMO, the company raised $105 million in funding. The company is developing an RNA analysis platform to detect colorectal cancer (to be launched in 2023).

A clinical study showed that when compared against the gold-standard colonoscopy, the platform demonstrated better sensitivity data in detecting advanced adenomas and colorectal cancer than other non-invasive tests.

Dr. Gareer says Geneoscopy is going to increasing the number of colonoscopies being performed. However, it's obvious to me that digital biology is disrupting not just GI but many other specialties that are diagnosing cancer.

I couldn't hold my curiosity and asked quite directly. Should gastroenterologists be worried about them? Should Cologuard be worried? Should Medtronic with its AI-based polyp detection system be worried? Because when there's a test that's going to detect adenomas with a fair degree of accuracy, why bother with diagnostic procedures? Dr. Gareer had a different and interesting view.

As readers of Scope Forward, you already know my take. With more data, digital biology innovations such as RNA and DNA tests combined with machine learning would get extremely sophisticated. It'll even be able to predict things that we just can't with traditional approaches. Dr. Haytham completely agreed.
...more
39min
July 22, 2022 Sonia Grego: Oura Ring for sleep. WHOOP for activity. Now, Coprata Smart Toilet for stool.
In this episode of The Scope Forward Show, Praveen Suthrum interviews Sonia Grego (Duke Professor and Co-Founder at Coprata Inc). The Coprata toilet captures lots of data post flush, runs #AI algorithms on the data and provides the analysis to both patients and doctors.

Watch this insightful interview to understand why smart toilets are essential for proactive (not reactive) GI care.

Watch the interview- https://lnkd.in/dkY4qmpE

#data #digitalhealth #gastroenterology #ibs #stool #ai #engineering #innovation #scopeforward
...more
29min
July 07, 2022 Demand is so high for GI psych - Dr. Riehl (Michigan Medicine) & Dr. Simons (Cleveland Clinic)
While COVID was on and people sought help through meditation apps, the business world of behavioral health made a big announcement. Headspace (an app started by a former Buddhist monk) merged with Ginger.io to create Headspace Health in a $3 billion merger. You read that right.

It's only natural that behavioral health showed up in gastroenterology. Curious, I reached out to GI psychologists Dr. Megan Riehl from Michigan Medicine and Dr. Madison Simons from Cleveland Clinic. What were these large institutions up to in this space? Why were they hiring psychogastroenterologists? Was there patient demand for something like this? What role would cognitive behavior therapy play in digital health?

This is an evolving space with high demand - especially for those GI conditions that don't have straightforward solutions. Mental health and its role in the making and management of GI conditions is a space to watch.

The brain-gut axis has a definite role to play in GI's future. Watch this one.
...more
37min
June 30, 2022 Matt Schwartz: Huge opportunity to add a digital layer to GI and endoscopy
In this episode of The Scope Forward Show, Praveen Suthrum interviews Matt Schwartz CEO & Co-founder of Virgo.

Virgo has captured 400,000 endoscopy videos so far and that number is growing exponentially. Virgo has also partnered with pharmaceutical companies to recruit the right candidates for clinical trials which led to a fundraise of $8 million with FCA Venture Partners and a soon-to-be-announced strategic investor.

Watch this insightful interview to understand why 'data is the new oil' and how Virgo will dramatically influence GI care in the coming years-https://www.youtube.com/watch?v=5XUvl7RDzsQ
#data #gastroenterology #scopeforward #endoscopy #AI #clinicaltrials
...more
39min
June 23, 2022 Dr. Fehmida Chipty: From GI doc to COO of digital health startup
In this episode of The Scope Forward Show, Praveen Suthrum interviews Fehmida Chipty, MD, COO of digital health startup Satya Health Sciences | NovoLiver.

Watch Dr. Fehmida Chipty's fascinating narration unfold fundamental issues of #gastroenterology. Why did she quit GI? What are the problems that we don't talk about? Why don't physicians ask for help? What her concerns are with our healthcare system? Is doing #colonoscopy after colonoscopy really helping solve for cancer?

Your future self will want you to watch this one.
...more
38min
June 16, 2022 Abe M'Bodj: How Will Private Equity Respond To Recession?
In this episode of The Scope Forward Show, Praveen Suthrum interviews Abe M'Bodj, Vice President at Westcove Partners, a leading healthcare-focused investment bank. During an economic downturn, would PE investments increase or drop? About 10% of the entire gastroenterology industry is under some form of PE as of mid-2022. What effect would recession have on "second bites" (exits) of existing PE platforms? What impact would it have on valuations? What big announcements can we expect before the end of the year? Find out more in this exclusive interview.
...more
44min
June 09, 2022 Aonghus Shortt: "If you capture more data, you should be able to do a better diagnosis."
We are back with the next season of The Scope Forward Show where you'll get to meet innovators and leaders who are reimagining the healthcare system.

The next phase of GI depends on innovators such as Aonghus and FoodMarble. Why? Because the industry is shifting from under our feet. Four trends are influencing GI: exponential technologies, consolidation, big brothers (such as hospitals, insurances) and changes in patient behavior.

FoodMarble, a tiny device that analyzes digestive disorders such as IBS and SIBO, comes squarely in the middle of these trends. After selling 30,000 devices, what do they know about patients with IBS that a private practice does not? How can this be a new revenue-generating ancillary opportunity?

The story of its growth is also interesting. An engineer gets an idea after seeing his girlfriend suffer. Ideates and develops the device in Ireland and China. Raises $6 million and sells globally - more than 2/3rd in the US. It's indicative of how the next phase of innovation would happen.

Aonghus says, with "more data", you can come up with a "better diagnosis". True. Welcome to the evolving world of data-driven GI.
...more
25min
November 25, 2021 Dr. Sravanthi Parasa: "When a phone can recognize my face, why can’t software recognize a polyp?"
Every so often an interview reminds me yet again that the future is coming at us faster -- much faster. I'm still wrapping my head around what gastroenterologist and AI researcher Dr. Sravanthi Parasa told me: there would be a "1,000 algorithms" in 3 years in GI.

This is big implications for the business of gastroenterology. The AI will indeed operate and guide us like a self driving car. In such a world, how would your role evolve as the endoscopist? What would happen to all the PE valuations that are based on GI manual productivity? How would the workflow change when you combine liquid biopsy and AI? Would your practice prefer hiring an AI vs. an average endoscopist? What if the insurance mandates the use of AI?

Welcome to GI 2.0.
**
Watch more interviews: https://www.nextservices.com/interviews/
**
#gastroenterology #TheScopeForwardShow #nextservices #scopeforward #healthcare #technology #healthtech #aiingi #artificialintelligence #digitalhealth
...more
36min
October 29, 2021 Sam Holliday (CEO of Oshi Health): "My goal would be to cover all 50 states by the end of 2022."
Praveen Suthrum interviews Sam Holliday, CEO of the digital health company, Oshi Health. Two weeks ago, Oshi Health raised $23 million from well-known investors. It reinforces the fact that the landscape of gastroenterology is shifting toward digitization.
In this interview, Sam Holliday (CEO of Oshi Health) talks about their plans to scale across all 50 states by the end of 2022. They also plan to hire gastroenterologists and partner with GI practices. Learn about what's attracting investor interest in digitization of gastroenterology.
**
Watch more interviews: https://www.nextservices.com/interviews/
**
#gastroenterology #TheScopeForwardShow #nextservices #scopeforward #healthcare #technology #healthtech #leadership #digitalhealth #oshihealth #digitalhealth #digitalGI
...more
30min
October 14, 2021 Dr. Aja McCutchen: "How can we be so under-represented and expect to make a big change?"
In a data driven world, it'll become acutely obvious that our system is broken in terms of racial disparity. The drugs we have don't work for all demographics. GI physician community is quite imbalanced in terms of race. Patients and future physicians will gravitate toward a more inclusive medical practice.
It's already apparent that social determinants of health (SDH) influence health outcomes. Whether we recognize it or not, diversity and inclusion affects all of gastroenterology. It'll affect the future of GI. It'll affect private practice GI -- for sure.
One of the most qualified people in our industry to understand this important topic is Dr. Aja McCutchen. She's a Board Member of United Digestive and Chair of Diversity, Equity and Inclusion at Digestive Health Physicians Association (DHPA).
In this interview, she shares her story - from the suburbs of Cleveland ("crazy Dave" drew her to medicine) to leading the field (GI has only 1% African American women). You'll clearly understand the importance of paying attention to diversity and inclusion.
#gastroenterology #TheScopeForwardShow #nextservices #scopeforward #healthcare #technology #healthtech #leadership #digitalhealth #racism #DHPA #inequity
...more
32min

FAQs about Scope Forward:

How many episodes does Scope Forward have?

The podcast currently has 77 episodes available.